Doctor Kei Morikawa
Kumamoto University, Kumamoto (Japan)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Non-steroidal mineralocorticoid receptor antagonist, finerenone, attenuates obesity- and hypertension-induced cardiomyocyte hypertrophy in a blood pressure-independent manner.
Event: ESC Congress 2023
Topic: Pharmacotherapy
Session: Experimental therapies for heart failure
